From October 1, 2021 to December 31, 2021, the company has repurchased 20,452 shares, representing 0.17% for KRW 2,279.19 million. With this, the company has completed the repurchase of 110,665 shares, representing 0.93% for KRW 14,904.82 million under the buyback announced on October 15, 2020.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,02,300 KRW | -2.85% | +2.30% | -21.85% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.85% | 98Cr | |
+17.07% | 4.26TCr | |
+19.98% | 2.1TCr | |
+17.26% | 1.49TCr | |
+16.77% | 1.45TCr | |
+47.95% | 1.26TCr | |
-0.05% | 678.76Cr | |
-10.33% | 657Cr | |
+14.13% | 562.47Cr | |
+4.17% | 465.88Cr |
- Stock Market
- Equities
- A185750 Stock
- News Chong Kun Dang Pharmaceutical Corp.
- Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 15, 2020.